Companies: 10,795·Total market cap: $144.5T
Psyence Biomedical Ltd.

Psyence Biomedical Ltd.

PBMNASDAQHealthcare● Active
$3.60
+$0.09(+2.56%)
Market Cap$68468
P/E Ratio
52W High$468.35938
52W Low$1.92
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Psyence Biomedical Ltd. (PBM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001985062 · PBM · NASDAQ · as of Jun 8, 2026

Filing snapshot

157
Total Filings
6-K
Latest Form
2026-06-05
Most Recent
2021
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001985062 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-06-25
Fiscal Year End
Jun 25, 2025
Accession No.
0001213900-25-057893
Primary Document
ea0246623-20f_psyence.htm
Source: data.sec.gov · CIK 0001985062 · Accession 0001213900-25-057893

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-05
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-05
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-06-03
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-23
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-20
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-17
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-15
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-02
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-02-20
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-19
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-02-19
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-02-13
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-02-12
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-01-29
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-01-27
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-01-14
View
Showing 1–15 of 157 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001985062  |  Exchange: NASDAQ · Healthcare

Psyence Biomedical Ltd. (NASDAQ: PBM) has submitted 157 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001985062, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Psyence Biomedical Ltd.'s most comprehensive regulatory disclosure. The most recent Psyence Biomedical Ltd. 10-K was filed on 2025-06-25 for fiscal year ending 2025. Historical PBM 10-K annual reports are available from 2023 through 2025.

Investors researching Psyence Biomedical Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

PBM SEC Filings · 8 questions

Psyence Biomedical Ltd. (PBM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 157 filings and access original documents at no cost. Psyence Biomedical Ltd.'s CIK is 0001985062.

PBM SEC filingsPsyence Biomedical Ltd. SEC documentsfind PBM 10-K